Understanding How PPAR-Gamma Agonists Work
The peroxisome proliferator-activated receptor, PPAR-gamma agonist, class of drugs is the fastest-growing class of drugs in the type 2 diabetes market. Currently, GlaxoSmithKline's Avandia and Takeda's Actos are the fastest-growing class of drugs in the type 2 diabetes market.
Understand How Recent Safety Concerns Will Affect PPAR-Gamma Agonists
Recent evidence has suggested that Takeda's Actos actually lowers heart risk. This calls into question what makes Avandia a dangerous drug, if it is even a dangerous drug.
Related Links:
Legal View: Avandia
Troubled Diabetes Drug Avandia in Spotlight
Avandia Maker Sued Over Heart Attack
Heart Doctors Spar Over Diabetes Drug
Steve Nissen Accused Of ‘Data Snooping’